Inicio › Lupus › Texas

Ensayos clínicos de Lupus en Texas

26 estudios sobre Lupus buscan participantes en Texas.

Ciudades en Texas

Texto oficial del estudio (inglés)

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Research Site, Austin
Research Site, Baytown
Research Site, Colleyville
y 3 más

ReclutandoFase 3

Edades de 18 a 70 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07430306

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Epic Medical Research /ID# 279180, Red Oak

ReclutandoFase 1

Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07607964

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Amarillo Medical Specialists Rheumatology, Amarillo
Amarillo Center for Clinical Research, Amarillo
Arthritis and Rheumatology Research Institute, Frisco
y 5 más

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07438496

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site, Allen
Research Site, Mesquite

ReclutandoFase 1

Edades de 18 a 65 · Todos los sexos · Actualizado el 18 sept 2026 · NCT07201558

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Amarillo Center for Clinical Research, Amarillo
Precision Comprehensive Clinical Research Solutions - Colleyville, Colleyville
Precision Comprehensive Clinical Research Solutions, Euless
y 4 más

ReclutandoFase 2

Edades de 18 a 74 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07409181

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

North Texas Center for Clinical Research, Frisco
Accurate Clinical Research, Humble

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07355218

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Baylor College of Medicine, Houston

ReclutandoFase 1

Edades de 18 a 60 · Todos los sexos · Actualizado el 14 sept 2026 · NCT06975787

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

The University of Texas Southwestern Medical Center, Dallas

ReclutandoFase 2

Edades de 12 a 70 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Allen Arthritis, Allen
Arthritis and Rheumatology Research Institute PLLC, Allen
Arthritis Care of Texas, Corpus Christi

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07332481

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Research Site, El Paso
Research Site, Houston

ReclutandoFase 3

Edades de 5 a 17 · Todos los sexos · Actualizado el 10 sept 2026 · NCT05835310

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sl0044 50738, Bellaire
Sl0044 50781, El Paso
Sl0044 50673, Fort Worth
y 7 más

ReclutandoFase 3

Edades de 16 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06617325

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Arthritis Care of Texas - Corpus Christi, Corpus Christi
Lone Star Arthritis & Rheumatology Associates, P.C., Denton
El Paso Medical Research Institute (MedResearch, Inc), El Paso
y 1 más

ReclutandoEstudio observacional

Edades de 16 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07175285

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of Texas MD Anderson Cancer Center, Houston

ReclutandoFase 1/2

Edades de 18 a 65 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06121297

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Texas Transplant Institute, San Antonio

ReclutandoFase 2

Edades de 12 a 65 · Todos los sexos · Actualizado el 24 ago 2026 · NCT07053800

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Integrative Rheumatology of South Texas - Harlingen /ID# 276458, Harlingen

ReclutandoFase 1

Edades de 18 a 75 · Todos los sexos · Actualizado el 10 ago 2026 · NCT06977724

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Prolato Clinical Research Center, Houston

ReclutandoFase 2

Edades de 18 a 100 · Todos los sexos · Actualizado el 30 jul 2026 · NCT05268289

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Rheumatology Care Center, PLLC, Bellaire
Texas Arthritis Center, El Paso
Novel Research, LLC., Houston
y 3 más

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 30 jul 2026 · NCT07201129

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Investigative Site, Allen
Investigative Site, Arlington
Investigative Site, Colleyville

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07260877

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Accurate Clinical Research, League City
Epic Medical Research, Red Oak

ReclutandoFase 3

Edades de 12 a 100 · Todos los sexos · Actualizado el 8 jul 2026 · NCT06133972

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Stryde Research, Plano
Tranquil Clinical Research, Webster

ReclutandoFase 1

Edades de 18 a 70 · Todos los sexos · Actualizado el 5 jun 2026 · NCT06613360

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

US04-0, Irving
US02-0, San Antonio

ReclutandoFase 1/2Se aceptan voluntarios sanos

Edades de 18 a 70 · Todos los sexos · Actualizado el 2 jun 2026 · NCT06625671

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 may 2026 · NCT04751396

Lupus Landmark Study: A Prospective Registry and Biorepository

UT Southwestern Medical Center, Dallas

ReclutandoEstudio observacional

Edades de 18 a 110 · Todos los sexos · Actualizado el 15 abr 2026 · NCT05934149

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at Houston, Houston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 abr 2026 · NCT06434363

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Climb Bio Investigative Site #100104, Allen
Climb Bio Investigative Site #100101, San Antonio

ReclutandoFase 1

Edades de 18 a 65 · Todos los sexos · Actualizado el 27 mar 2026 · NCT07011043

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.